Search results
Why Novavax (NVAX) Stock Was Down 13% on Thursday
Zacks via Yahoo Finance· 2 years agoShares of Novavax, Inc. NVAX dropped 13.3% on Sep 22 after analysts at JP Morgan recently downgraded the stock’s recommendation from Neutral to...
Some Novavax, Inc. (NASDAQ:NVAX) Analysts Just Made A Major Cut To Next Year's Estimates
Simply Wall St. via Yahoo Finance· 2 years agoMarket forces rained on the parade of Novavax, Inc. (NASDAQ:NVAX) shareholders today, when the...
This Just In: Analysts Are Boosting Their Novavax, Inc. (NASDAQ:NVAX) Outlook for This Year
Simply Wall St. via Yahoo Finance· 12 months agoShareholders in Novavax, Inc. (NASDAQ:NVAX) may be thrilled to learn that the analysts have just...
Why Wall Street Thinks Novavax Is a No-Brainer Stock to Buy Right Now
Motley Fool· 2 years agoNovavax (NASDAQ: NVAX) is very late to the party in entering the COVID-19 vaccine market. Wall...
Why Novavax Stock Hit a Fresh 52-Week Low Today
Motley Fool· 2 years agoShares of the recombinant-protein vaccine specialist Novavax (NASDAQ: NVAX) were down by a noteworthy 9.2% on heavy volume as of 9:55 a.m. ET on...
3 Turnaround Stocks With 151% to 600% Upside in 2024, According to Select Wall Street Analysts
Motley Fool via Yahoo Finance· 4 months agoFor optimists, 2023 was a stellar year. The ageless Dow Jones Industrial Average climbed to a fresh...
Novavax Dive Continues As FDA Reviews New Covid Shot Information
Investor's Business Daily· 2 years agoThree days after Food and Drug Administration advisors endorsed authorization for Novavax's Covid...
Novavax (NVAX) Stock Increases 9% in a Month: Here's Why
Zacks via Yahoo Finance· 8 months agoThis growth in Novavax (NVAX) is likely due to the rising COVID-19 infection cases in the United...
Let the Market’s Shakeout Finish Before Buying Novavax Stock
InvestorPlace via Yahoo Finance· 2 years agoNovavax (NVAX) stock traders may be tempted to buy the dip after a share-price crash. Yet,...
Novavax Stock (NASDAQ:NVAX): Too Much Bad News Can Fuel a Reversal
TipRanks via Yahoo Finance· 3 months agoBy most measures, investors have reason to be skeptical about vaccine specialist Novavax...